Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 422

Cited In for PubMed (Select 12711465)

1.

The Nucleocapsid Protein of Human Coronavirus NL63.

Zuwała K, Golda A, Kabala W, Burmistrz M, Zdzalik M, Nowak P, Kedracka-Krok S, Zarebski M, Dobrucki J, Florek D, Zeglen S, Wojarski J, Potempa J, Dubin G, Pyrc K.

PLoS One. 2015 Feb 20;10(2):e0117833. doi: 10.1371/journal.pone.0117833. eCollection 2015.

2.

Coronavirus cell entry occurs through the endo-/lysosomal pathway in a proteolysis-dependent manner.

Burkard C, Verheije MH, Wicht O, van Kasteren SI, van Kuppeveld FJ, Haagmans BL, Pelkmans L, Rottier PJ, Bosch BJ, de Haan CA.

PLoS Pathog. 2014 Nov 6;10(11):e1004502. doi: 10.1371/journal.ppat.1004502. eCollection 2014 Nov. Erratum in: PLoS Pathog. 2015 Feb;11(2):e1004709.

3.

Dissecting virus entry: replication-independent analysis of virus binding, internalization, and penetration using minimal complementation of β-galactosidase.

Burkard C, Bloyet LM, Wicht O, van Kuppeveld FJ, Rottier PJ, de Haan CA, Bosch BJ.

PLoS One. 2014 Jul 15;9(7):e101762. doi: 10.1371/journal.pone.0101762. eCollection 2014.

4.

Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus.

Lundin A, Dijkman R, Bergström T, Kann N, Adamiak B, Hannoun C, Kindler E, Jónsdóttir HR, Muth D, Kint J, Forlenza M, Müller MA, Drosten C, Thiel V, Trybala E.

PLoS Pathog. 2014 May 29;10(5):e1004166. doi: 10.1371/journal.ppat.1004166. eCollection 2014 May.

5.

Effects of Toll-like receptor stimulation on eosinophilic infiltration in lungs of BALB/c mice immunized with UV-inactivated severe acute respiratory syndrome-related coronavirus vaccine.

Iwata-Yoshikawa N, Uda A, Suzuki T, Tsunetsugu-Yokota Y, Sato Y, Morikawa S, Tashiro M, Sata T, Hasegawa H, Nagata N.

J Virol. 2014 Aug;88(15):8597-614. doi: 10.1128/JVI.00983-14. Epub 2014 May 21.

6.

Early response to the emergence of influenza A(H7N9) virus in humans in China: the central role of prompt information sharing and public communication.

Vong S, O'Leary M, Feng Z.

Bull World Health Organ. 2014 Apr 1;92(4):303-8. doi: 10.2471/BLT.13.125989. Epub 2013 Dec 16.

7.

Coronavirus replicase-reporter fusions provide quantitative analysis of replication and replication complex formation.

Freeman MC, Graham RL, Lu X, Peek CT, Denison MR.

J Virol. 2014 May;88(10):5319-27. doi: 10.1128/JVI.00021-14. Epub 2014 Mar 12.

8.

Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain.

Siu KL, Chan CP, Kok KH, Chiu-Yat Woo P, Jin DY.

Cell Mol Immunol. 2014 Mar;11(2):141-9. doi: 10.1038/cmi.2013.61. Epub 2014 Feb 10.

9.
10.

Epidemiology of human respiratory viruses in children with acute respiratory tract infections in Jinan, China.

Lu Y, Wang S, Zhang L, Xu C, Bian C, Wang Z, Ma Y, Wang K, Ma L, Meng C, Ni C, Tong J, Li G, Han J.

Clin Dev Immunol. 2013;2013:210490. doi: 10.1155/2013/210490. Epub 2013 Dec 2.

11.

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.

Chen WH, Du L, Chag SM, Ma C, Tricoche N, Tao X, Seid CA, Hudspeth EM, Lustigman S, Tseng CT, Bottazzi ME, Hotez PJ, Zhan B, Jiang S.

Hum Vaccin Immunother. 2014;10(3):648-58. Epub 2013 Dec 30.

12.

The legacies of SARS - international preparedness and readiness to respond to future threats in the Western Pacific Region.

Mackenzie JS, Merianos A.

Western Pac Surveill Response J. 2013 Jul 2;4(3):4-8. doi: 10.5365/WPSAR.2013.4.3-004. eCollection 2013 Jul-Sep. No abstract available.

13.

Aptamer-based therapeutics: new approaches to combat human viral diseases.

Shum KT, Zhou J, Rossi JJ.

Pharmaceuticals (Basel). 2013 Nov 25;6(12):1507-42. doi: 10.3390/ph6121507.

14.

Receptor recognition and cross-species infections of SARS coronavirus.

Li F.

Antiviral Res. 2013 Oct;100(1):246-54. doi: 10.1016/j.antiviral.2013.08.014. Epub 2013 Aug 29. Review.

15.

Receptor-binding domain as a target for developing SARS vaccines.

Zhu X, Liu Q, Du L, Lu L, Jiang S.

J Thorac Dis. 2013 Aug;5 Suppl 2:S142-8. doi: 10.3978/j.issn.2072-1439.2013.06.06.

16.

From SARS coronavirus to novel animal and human coronaviruses.

To KK, Hung IF, Chan JF, Yuen KY.

J Thorac Dis. 2013 Aug;5 Suppl 2:S103-8. doi: 10.3978/j.issn.2072-1439.2013.06.02.

17.

Coronaviruses lacking exoribonuclease activity are susceptible to lethal mutagenesis: evidence for proofreading and potential therapeutics.

Smith EC, Blanc H, Vignuzzi M, Denison MR.

PLoS Pathog. 2013 Aug;9(8):e1003565. doi: 10.1371/journal.ppat.1003565. Epub 2013 Aug 15.

18.

Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.

Hendrickson CM, Matthay MA.

Semin Respir Crit Care Med. 2013 Aug;34(4):475-86. doi: 10.1055/s-0033-1351122. Epub 2013 Aug 11. Review.

19.

Clinical impact of human coronaviruses 229E and OC43 infection in diverse adult populations.

Walsh EE, Shin JH, Falsey AR.

J Infect Dis. 2013 Nov 15;208(10):1634-42. doi: 10.1093/infdis/jit393. Epub 2013 Aug 6.

20.

The replication of a mouse adapted SARS-CoV in a mouse cell line stably expressing the murine SARS-CoV receptor mACE2 efficiently induces the expression of proinflammatory cytokines.

Regla-Nava JA, Jimenez-Guardeño JM, Nieto-Torres JL, Gallagher TM, Enjuanes L, DeDiego ML.

J Virol Methods. 2013 Nov;193(2):639-46. doi: 10.1016/j.jviromet.2013.07.039. Epub 2013 Aug 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk